Endosomal escape enhancing compounds facilitate functional delivery of extracellular vesicle cargo

Nanomedicine (Lond). 2019 Nov;14(21):2799-2814. doi: 10.2217/nnm-2019-0061. Epub 2019 Nov 14.

Abstract

Aim: Extracellular vesicles (EVs) are desirable delivery vehicles for therapeutic cargoes. We aimed to load EVs with Cre recombinase protein and determine whether functional delivery to cells could be improved by using endosomal escape enhancing compounds. Materials & methods: Overexpressed CreFRB protein was actively loaded into EVs by rapalog-induced dimerization to CD81FKBP, or passively loaded by overexpression in the absence of rapalog. Functional delivery of CreFRB was analysed using a HEK293 Cre reporter cell line in the absence and presence of endosomal escape enhancing compounds. Results: The EVs loaded with CreFRB by both active and passive mechanisms were able to deliver functional CreFRB to recipient cells only in the presence of endosomal escape enhancing compounds chloroquine and UNC10217938A. Conclusion: The use of endosomal escape enhancing compounds in conjunction with EVs loaded with therapeutic cargoes may improve efficacy of future EV based therapeutics.

Keywords: Cre recombinase; UNC10217832A; chloroquine; endosomal escape; exosomes; extracellular vesicles; rapalog-induced dimerization; therapeutic delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport
  • Chloroquine / chemistry
  • Chloroquine / metabolism
  • Drug Liberation
  • Endosomes / metabolism*
  • Enhancer Elements, Genetic
  • Extracellular Vesicles / chemistry*
  • Extracellular Vesicles / metabolism
  • Gene Expression
  • HEK293 Cells
  • Humans
  • Integrases / chemistry*
  • Integrases / genetics
  • Integrases / metabolism
  • Nanocapsules / chemistry*
  • Particle Size
  • Protein Multimerization
  • Signal Transduction

Substances

  • Nanocapsules
  • Chloroquine
  • Cre recombinase
  • Integrases